artenimol has been researched along with Inflammatory Bowel Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, J; Lei, Y; Lei, Z; Liu, S; Liu, W; Wu, H; Yang, C; Yang, L; Yang, Y; Zhang, X | 1 |
| Chen, Z; Ge, X; Lv, F; Xu, Z; Yang, Y; Zhang, K | 1 |
| Cai, WY; Chen, Y; Li, Q; Li, YJ; Wang, YJ; Weng, XG; Yan, SC; Yang, Q; Zhu, XX | 1 |
3 other study(ies) available for artenimol and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Dihydroartemisinin ameliorates dextran sulfate sodium induced inflammatory bowel diseases in mice.
Topics: Animals; Antimalarials; Artemisinins; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Microbiome; Inflammatory Bowel Diseases; Male; Mice; Mice, Inbred C57BL | 2020 |
The effects of dihydroartemisinin on inflammatory bowel disease-related bone loss in a rat model.
Topics: Animals; Anti-Inflammatory Agents; Artemisinins; Bone Density Conservation Agents; Bone Diseases, Metabolic; Dextran Sulfate; Disease Models, Animal; Inflammatory Bowel Diseases; Injections, Intraperitoneal; Male; Rats, Sprague-Dawley; Treatment Outcome | 2018 |
Dihydroartemisinin Regulates the Th/Treg Balance by Inducing Activated CD4+ T cell Apoptosis via Heme Oxygenase-1 Induction in Mouse Models of Inflammatory Bowel Disease.
Topics: Animals; Apoptosis; Artemisinins; Colitis; Disease Models, Animal; Enzyme Induction; Heme Oxygenase-1; Inflammatory Bowel Diseases; Lymphocyte Activation; Lymphocyte Subsets; Mice; Oxazolone; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory; Trinitrobenzenesulfonic Acid | 2019 |